GRPH Shares Outstanding History
Below is a table of the GRPH shares outstanding history going back to 6/25/2021:

Date GRPH Shares Outstanding

Also see: GRPH Market Cap History
GRPH Historical Shares Outstanding:
+7.45% CAGR
GRPH Historical Shares Outstanding: +7.45% CAGR

Mouse over chart for data details
6/25/2021 ...5/5/2022
Graphite Bio is a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases. Co.'s primary product candidate GPH101 is an approach with the potential to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. Co.'s pipeline also includes GPH102 for beta-thalassemia and GPH201 for X-linked severe combined immunodeficiency syndrome; GPH301 for Gaucher disease and an early-stage research program for alpha-1 antitrypsin deficiency; and various undisclosed programs in both hematopoietic stem cells and other cell types. We show 5 historical shares outstanding datapoints in our coverage of GRPH's shares outstanding history.

Understanding the changing numbers of GRPH shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GRPH versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GRPH by allowing them to research GRPH shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree GRPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Graphite Bio (GRPH) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

GRTS Shares Outstanding History
GRTX Shares Outstanding History
GTBP Shares Outstanding History
GTHX Shares Outstanding History
GTS Shares Outstanding History
GTXI Shares Outstanding History
HAE Shares Outstanding History
HAIR Shares Outstanding History
HALO Shares Outstanding History
HARP Shares Outstanding History
More Healthcare companies »


GRPH Shares Outstanding History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.